UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056438
Receipt number R000064495
Scientific Title Study on the anesthetic efficacy of re-modified TAPA administered at the ninth intercostal space.
Date of disclosure of the study information 2024/12/20
Last modified on 2025/04/03 11:53:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on the anesthetic efficacy of re-modified TAPA administered at the ninth intercostal space.

Acronym

Study on the anesthetic efficacy of re-modified TAPA administered at the ninth intercostal space.

Scientific Title

Study on the anesthetic efficacy of re-modified TAPA administered at the ninth intercostal space.

Scientific Title:Acronym

Study on the anesthetic efficacy of re-modified TAPA administered at the ninth intercostal space.

Region

Japan


Condition

Condition

Healthy volunteers

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Assess the anesthetic efficacy of re-modified TAPA administered at the ninth intercostal space in healthy adult volunteers.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Analgetic area

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Insert a needle into the SEDIC from the ninth intercostal space and administer 20 mL of 0.2% ropivacaine per side.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >

Gender

Male and Female

Key inclusion criteria

Healthy adult volunteers with ASA-PS I.

Key exclusion criteria

Subjects are excluded if they are younger than 20-yr or older than 50-yr, have a history of allergy to local anesthetics, have a neurological disorder affecting the corresponding region, using analgesics (including cold medicine) or steroids, or are pregnant.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Yuichi
Middle name
Last name Ohgoshi

Organization

Keiyu Hospital

Division name

Department of Anesthesiology

Zip code

220-8521

Address

3-7-3 Minatomirai, Nishi-ku, Yokohama, Kanagawa, 220-8521, Japan

TEL

+81-45-2218181

Email

ohgoshi22@gmail.com


Public contact

Name of contact person

1st name Yuichi
Middle name
Last name Ohgoshi

Organization

Keiyu Hospital

Division name

Department of Anesthesiology

Zip code

220-8521

Address

3-7-3 Minatomirai, Nishi-ku, Yokohama, Kanagawa, 220-8521, Japan

TEL

+81452218181

Homepage URL


Email

ohgoshi22@gmail.com


Sponsor or person

Institute

Keiyu Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical and Health Resources Research Institute

Address

4-38-7, Higashi-Ikebukuro, Toshima-ku, Tokyo 170-0013, Japan

Tel

0359048534

Email

ohgoshi22@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

けいゆう病院


Other administrative information

Date of disclosure of the study information

2024 Year 12 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

10

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2024 Year 11 Month 13 Day

Date of IRB

2024 Year 12 Month 04 Day

Anticipated trial start date

2024 Year 12 Month 20 Day

Last follow-up date

2025 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 12 Month 12 Day

Last modified on

2025 Year 04 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064495